Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Multicenter Phase II Trial of Capecitabine Versus S-1 as First-line Treatment in Elderly Patients With Advanced or Recurrent Unresectable Gastric Cancer

NCT00278863 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT00278863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00278863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Multicenter Phase II Trial of Capecitabine Versus S-1 as First-line Treatment in Elderly Patients With Advanced or Recurrent Unresectable Gastric Cancer
Lead sponsor
Asan Medical Center
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2004
Completion date
January 31, 2007
Enrollment
96 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer